JAMA Network
About The Study: The results of this systematic review and meta-analysis suggest that integrating magnetic resonance imaging (MRI) in prostate cancer screening pathways is associated with a reduced number of unnecessary biopsies and overdiagnosis of insignificant prostate cancer while maintaining clinically significant prostate cancer detection as compared with prostate-specific antigen (PSA)-only screening.
Authors: Shahrokh F. Shariat, M.D., D.Dr.(hc), of Medical University Vienna in Vienna, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2024.0734)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
